Signaling Pathways - Aminopeptidases - p53-MDM2 interaction - EZH1 - Androgen Receptors
清除全部
- A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂
- B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂
- B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂
- A8804 AMG2322 CitationTarget: p53-MDM2 interactionSummary: p53-MDM2抑制剂
- A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
- A8621 Bestatin hydrochloride中文名: 盐酸乌苯美司Target: AminopeptidasesSummary: 氨肽酶N(APN/CD13)和氨肽酶B抑制剂。
- A2005 Nutlin-3bTarget: p53-MDM2 interactionSummary: MDM2/p53抑制剂
- A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂
- A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体(Androgen receptor)拮抗剂